TMEM16A has been implicated in numerous cancers, including head and neck, esophageal, gastric, colorectal, lung, breast, prostate, pancreatic and glioma [reviewed recently by Wang et al. (2017)]. This evidence concerns the gene ANO1 and central nervous system cancer.